Gene expression can be regulated at multiple levels, including transcription, RNA processing, RNA localization, translation and, finally, RNA turnover. RNA degradation may occur at points along the processing pathway or during translation as it undergoes quality control by RNA surveillance systems. Alternatively, mRNAs may be subject to regulated degradation, often mediated by cis-encoded determinants in the mRNA sequence that, through the recruitment of trans factors, determine the fate of the mRNA. The aim of the present review is to highlight mechanisms of regulated and quality-control RNA degradation in eukaryotic cells, with an emphasis on mammals.
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AUBPs are not known to possess intrinsic nucleolytic activities. Instead, they activate mRNA decay through the recruitment of cellular mRNA decay machineries. Biochemical studies of the AUBPs TTP, BRF1 and KSRP demonstrated that they associate with a variety of decay factors, including deadenylases, decapping factors, as well as 5 →3 and 3 →5 exonucleolytic factors [7] . Meanwhile, stabilizing AUBPs, such as HuR, may outcompete destabilizing AUBPs for ARE binding to promote RNA stability [8] .
Many AUBPs display tissue-or cell-type-specific expression patterns. For example, among the stabilizing AUBPs, HuR is more ubiquitously expressed than the other Hu family proteins, which show tissue-specific expression mostly limited to neuronal cell types [4] . AUBPs are often modified in response to external signalling cues or changing environmental stimuli, and this may alter their ability to regulate ARE mRNAs. For instance, when upstream kinase pathways are activated, destabilizing AUBPs such as KSRP, TTP and BRF1 are phosphorylated, and this limits their ability to activate RNA decay [9] . Under conditions of genotoxic stress, HuR relocalizes from the nucleus to the cytoplasm, enhancing its stabilizing effect on ARE mRNA [10] . Thus ARE mRNA decay can be regulated by external cues, thereby controlling the expression of ARE mRNAencoded proteins.
GRE (GU-rich element)-mediated decay
The GRE is another cis-encoded determinant known to regulate mRNA stability. The GRE sequence, UGUUUGUUUGU, was originally identified through computational analysis of unstable mRNAs in primary T-cells [11] . More recently, GREs were also found to be enriched among unstable transcripts in muscle cells [12] . The RNA-binding protein CUGBP-1 (CUG-binding protein 1) has been shown to mediate GRE mRNA instability [11] . Although the mechanism of GRE-mediated decay is not well established, human CUGBP-1 and the Xenopus homologue of CUGBP-1, called EDEN-BP (embryo deadenylation element-binding protein), promote deadenylation of mRNA [11] . Additionally, CUGBP-1 is thought to mediate alternative splicing [13] . Putative GRE-containing mRNAs include those important for transcription, apoptosis, RNA processing, cell division, signalling and cellular metabolism in developing muscle cells, T-cells and HeLa cells [11, 12, 14] . Future studies should reveal the specific mechanism of GREmediated decay and whether this is a regulated mRNAdecay pathway. Moreover, CUGBP-1 has been implicated in muscular dystrophy [13] . It will be important to learn whether the decay function of CUGBP-1 plays a role in this disease.
RISC (RNA-induced silencing complex)-mediated mRNA decay miRNAs (microRNAs) and siRNAs (short interfering RNAs) are small non-coding RNAs that generally downregulate the expression of target mRNAs. These small noncoding RNAs are typically ∼ 22 nt in length and assemble into an RNP (ribonucleoprotein) effector complex called the RISC. Through RNA-RNA base-pairing interactions, the small RNAs guide RISC to target mRNAs for silencing [15] [16] [17] . When siRNAs or miRNAs form perfect base pairing with the target RNA, RISC triggers endonucleolytic target RNA cleavage, which is followed by exonucleolytic decay of the fragments. Upon imperfect base pairing, which is typical for miRNA-mRNA pairs in most eukaryotes, with the exception of plants, the target mRNAs are subject to translational repression and/or degradation initiated by deadenylation followed by decapping and exonucleolytic decay [15] [16] [17] [18] . Why some miRNA targets are degraded whereas others appear to be silenced only through translational repression remains unclear.
A large fraction of human mRNAs are predicted to be targets for miRNA regulation, but there have only been several hundred miRNAs identified [19] . A single miRNA is able to regulate multiple mRNAs due to the allowed mismatches in base pairing between the miRNA and target mRNA interaction. Evidence suggests that only the critical 'seed region' of the miRNA, nucleotides 2-8, must base-pair with full complementarity to the target mRNA sequence, and looser base pairing rules apply for other regions of the miRNA.
Production of miRNAs is required for viability of organisms, but individual miRNAs vary in expression according to tissue or cell type, developmental stage or environmental stimulus [20] . Individual miRNAs are often regulated at the level of transcription, processing and degradation, thus allowing for regulation of RISC target mRNAs in various cell types and physiological conditions [20] [21] [22] . Because a large number of mRNAs are likely to be subject to miRNA regulation, it is not surprising that miRNAs have been implicated in many biological processes as well as numerous diseases and pathologies [20, 21] .
Other mRNA decay pathways: histone mRNA decay and Staufen-mediated decay Histone mRNA is unique in that it is the only known mRNA that is not polyadenylated. Instead of a poly(A) tail, it contains a stem-loop structure at the 3 -end which is bound by the SLBP (stem-loop-binding protein) [23] . Histone mRNA and protein levels fluctuate during the cell cycle and peak at S-phase when more histones are required to package newly synthesized DNA. At the conclusion of S-phase, histone mRNA is rapidly degraded in a process that requires SLBP, translation of the histone mRNA and the decay factor Upf1 (up-frameshift 1), which interacts with SLBP [23] . Upf1 is an essential component of the NMD (nonsense-mediated mRNA decay) pathway (discussed below) and is thought to promote mRNA decay when it is recruited during translation termination. The degradation of histone mRNA involves oligouridylation at the 3 -end, a modification believed to stimulate decapping and exonucleolytic decay of the mRNA [23] .
Similar to SLBP, Stau1 (Staufen 1) is an RNA-binding protein that shows specificity for double-stranded RNA stem-loop structures and interacts with Upf1. Like SLBP, Stau1 also promotes the decay of bound mRNAs in a manner dependent on translation and the presence of Upf1 [24] . Although Stau1 substrate mRNAs are still being identified and validated, some may be important for the process of muscle cell differentiation [24] .
Quality-control RNA-decay pathways
RNAs are subject to quality control at many stages of biogenesis, including transcription, processing, localization and incorporation into RNP complexes. It is believed that the activity of RNA quality-control pathways along these steps is driven by a constant kinetic competition between the surveillance machinery and the functional reactions of the RNA [25, 26] . As RNAs progress through the stages of maturation, abnormal RNAs are more likely to suffer from compromised reaction kinetics, and thus will have a greater chance of being recognized by the RNA-surveillance machinery.
RNA quality control begins in the nucleus shortly after the start of transcription. Through a number of different mechanisms, the integrity of transcribed and processed nuclear RNA is assessed, and this includes the monitoring of RNA polymerase II transcripts, rRNAs, snRNAs (small nuclear RNAs), snoRNAs (small nucleolar RNAs) and tRNAs [25] . RNAs may be subject to a variety of processing steps and modifications, including 5 capping, splicing, trimming and excising, nucleotide modification and incorporation into RNP complexes. Aberrant RNAs are less likely to be processed correctly or in a kinetically favourable manner, and are therefore more likely to be recognized and degraded by the nuclear RNA-decay machinery, consisting mostly of 5 →3 and 3 →5 exonucleases. 3 →5 exonuclease activity is enhanced by oligo(A) addition on to the 3 end of RNAs by a dedicated polyadenylation complex called the TRAMP (Trf4-Air2-Mtr4p polyadenylation) complex [27] . In contrast with the generally stabilizing effect of a poly(A) tail, the oligo(A) tail added on to nuclear RNAs by the TRAMP complex promotes their decay, probably by serving as a bait for exonucleases. However, some aberrant RNA molecules escape nuclear surveillance and are exported to the cytoplasm, where cytoplasmic quality-control pathways, often linked to translation, act to clear these RNAs.
Nonsense-mediated mRNA decay mRNAs with nonsense mutations contain PTCs (premature translation-termination codons) and can potentially make Cterminally truncated proteins that, depending on the nature of the protein product, may be detrimental to cellular fitness. For instance, truncated proteins can lead to dominantnegative effects by not performing their intended function and titrating away interacting proteins. PTC-containing mRNAs are estimated to comprise 3-10% of cellular mRNAs [28] , and they may arise through mutations in genomic DNA, DNA recombination events or errors in transcription and RNA processing [28, 29] . A large fraction of PTC-containing mRNAs in mammalian cells are thought to be produced by unproductive alternative splicing [30] . PTC-containing mRNAs are detected and degraded in a quality-control process linked to translation termination called the NMD pathway.
One important question is how PTC-containing mRNAs are distinguished from those with normal termination codons. NMD is dependent on translation, and evidence suggests that PTC recognition is mediated by the RNP complex bound to the mRNA downstream of the termination codon during translation termination [29, 31, 32] . Termination codons in mammalian transcripts are usually found in the last exon proximal to the poly(A) tail, and the local mRNP (messenger RNP) environment at translation termination consists of PABP [poly(A)-binding protein] and the remaining 3 -UTR-bound proteins. This 3 -UTR mRNP is believed to enhance translation termination and prevent NMD [29, [31] [32] [33] . However, PTC-containing mRNAs exhibit an altered mRNP environment. Because translation is terminated distal to the 3 -end of the mRNA, more factors sitting on the mRNA body are retained, and the distance between the termination site and PABP is lengthened. This altered protein environment allows for NMD factors to be recruited to the terminating ribosome and trigger mRNA decay [29, [32] [33] [34] . An EJC (exonjunction complex), which is deposited upstream of exon-exon junctions after pre-mRNA splicing and is normally displaced from the mRNA during translation, strongly enhances NMD in mammalian cells when positioned downstream of a termination event [34, 35] .
One of the core NMD components, Upf1, is thought to facilitate the transition from PTC recognition to mRNA decay through interactions with translation-termination factors and cellular RNA-decay factors [36] . PTC-containing mRNAs are degraded through either of two pathways. The first pathway initiates through decapping and deadenylation, followed by exonucleolytic decay. Alternatively, the mRNA is degraded by endonucleolytic cleavage catalysed by an NMD factor, Smg6 (suppressor with morphogenetic effect on genitalia 6), followed by exonucleolytic decay of the mRNA fragments [32, 36] .
NMD is considered to be a surveillance system that safeguards against translation of aberrant mRNAs, but there is also evidence to suggest that some non-PTC-containing mRNAs are regulated through NMD [37] . It will be interesting to see how involved the NMD pathway may be in regulating mRNA degradation in cells.
Non-stop decay
mRNAs that lack termination codons are also targeted for rapid decay. These mRNAs could make abnormal proteins with C-terminal extensions which may be detrimental to the cell. Such mRNAs are thought to be produced by events such as aberrant polyadenylation or endonucleolytic cleavage within the mRNA-coding region, and are recognized and rapidly degraded in a translation-dependent manner via the non-stop mRNA decay pathway. Evidence from yeast suggests that when ribosomes translate through the poly(A) tail and stall at the very 3 -end of a non-stop mRNA, Ski7, a component of the cytoplasmic exosome homologous with eRF3 (eukaryotic translation release factor 3), interacts with the stalled ribosome and triggers the rapid degradation of the non-stop transcript [28] . Another class of aberrant mRNAs, where the normal termination codon is not recognized and translation terminates at a downstream site in the 3 -UTR, have been described [38] . These mRNAs are rapidly degraded in a translation-and deadenylation-dependent manner, but the mechanism of how they are distinguished from normal mRNAs and the prevalence of this as a form of RNA quality control remain to be determined.
NGD (no-go decay) and NRD (non-functional rRNA decay) pathways
Some aberrant mRNA molecules may contain obstacles, such as strong secondary structure, which prevent translation elongation of ribosomes and leads to stalled ribosome complexes and surveillance by the NGD pathway. NGD clears the stalled ribosomes and rapidly degrades the mRNA transcript [39] . In yeast, NGD is dependent on active translation and the activity of two proteins, Dom34 and Hbs1, which resemble eRF1 and eRF3 respectively [39] . These factors are believed to interact with the stalled ribosome and assist in the disassembly of the stalled complex, and trigger mRNA decay through endonucleolytic cleavage and subsequent exonucleolytic decay [39] .
Stalled ribosome complexes also lead to the rapid degradation of rRNA from the small ribosomal subunit. Although rRNAs are usually very stable, studies from yeast have demonstrated that mutant 18S rRNAs deficient in codon recognition are rapidly degraded via the NRD pathway [40, 41] . The mutant rRNAs assemble into small ribosome subunits, but induce translation defects that lead to ribosomal stalling. Decay of the 18S rRNA, like NGD, is dependent on Dom34 and Hbs1, but, unlike NGD, the rRNA is degraded by exonucleases and no endonucleases are thought to participate [41] . Separate studies of NGD and the NRD of 18S rRNA have shown that stalled ribosomes are cues that activate surveillance pathways to clear the stalled ribosome complex and degrade aberrant RNA molecules. An interesting question to address in the future is if both the mRNA and rRNA of the same stalled ribosome complex are degraded concurrently [41] .
The large ribosomal subunit rRNA is also subject to quality control inspection through an NRD pathway. For example, yeast 25S rRNA with a mutation in the peptidyltransferase centre renders the ribosome incapable of catalysing peptide bond formation. rRNAs with this mutation are rapidly degraded when compared with wildtype 25S rRNA [40, 41] . In contrast with the decay of 18S rRNA, the 25S rRNA decay is not dependent on translation, does not become incorporated into the translational pool of ribosomes and is probably recognized and degraded at some step during assembly [40, 41] , although the exact mechanisms of detection and decay remain to be determined.
miRNA decay
Because miRNAs are important regulators of posttranscriptional gene expression in many organisms, the maintenance of appropriate miRNA levels is critical, and misregulation of miRNAs has been implicated in pathologies such as cancer [20] . miRNAs are subject to regulation through transcription, processing and degradation, and recent studies from plants and nematode worms suggest that miRNA degradation is mediated by both 3 →5 and 5 →3 exonucleases [22] . Incorporation of miRNAs into RISCs or binding to target mRNAs is thought to stabilize miRNAs [22] . Additionally, modifications of the miRNA 3 -end, such as methylation or non-templated nucleotide addition (of either adenosines or uridines), have varying effects on the stability (both stabilizing and destabilizing) of the miRNA [22] . It remains to be determined how prevalent miRNA degradation as a post-transcriptional mechanism to regulate miRNA levels is in mammalian cells.
tRNA decay tRNAs act in concert with ribosomes to decode mRNAs and direct amino acid incorporation during protein synthesis. The biogenesis of tRNAs includes multiple modification and processing steps such as intron splicing, trimming of 5 -and 3 -ends, 3 -CCA nucleotide addition, and extensive base modifications [42] . tRNA molecules are highly processed and are thus subject to regulation at multiple points by RNAsurveillance pathways. At least two characterized qualitycontrol steps ensure the fidelity of cellular tRNAs. In the nucleus, improperly processed tRNAs are subject to 3 →5 exosome decay stimulated by poly(A) addition by the TRAMP complex, or 5 →3 exonucleolytic decay [25, 26] . In the cytoplasm, tRNAs lacking proper base modifications may be rapidly degraded through a 5 →3 exonuclease activity [43] . The exact mechanisms of recognition of these aberrant tRNAs by the quality-control machinery remains unclear and is a subject for further investigation.
Conclusions and future directions
RNA steady-state levels in cells are determined by two factors: the rate of RNA synthesis and the rate of RNA turnover. RNA turnover not only is important in the maintenance of cellular homoeostasis, but also is required to complement changes in the transcriptional programme that occur when the cell responds to challenges such as changing environmental conditions or various stimuli. Although progress has been made in recent years to shed light on to some of the underlying mechanisms that mediate RNA degradation, there are many unresolved questions left to explore. For instance, some basic understanding of the cis-encoded destabilizing elements and the trans factors that mediate regulated mRNA decay are known. But there is still much to learn about the various decay pathways that operate in the cell and the mechanisms by which they are regulated to co-ordinate post-transcriptional gene expression.
